The Latest Breaking News from Cigna

The celebrity investor has teamed up with a soft-spoken radiologist to tackle the USA’s healthcare crisis – and he has drug industry middlemen squarely in his sights, reports Io Dodds

Cigna is near a buy zone with earnings due on or around May 6.

Cigna (NYSE:CI) has outperformed the market over the past 15 years by 4.12% on an annualized basis producing an average annual return of 11.66%. Currently, Cigna has a market capitalization of $85.29 billion.

Cigna (NYSE:CI) has observed the following analyst ratings within the last quarter:

Teresa Ross llevaba meses planteando objeciones en el trabajo cuando sus jefes trajeron a un psicólogo con la esperanza de hacerle cuestionar su propia cordura.

Teresa Ross had been raising objections at work for months when her bosses brought in a psychologist hoping to make her question her own sanity.

Cigna (NYSE:CI) has outperformed the market over the past 20 years by 2.72% on an annualized basis producing an average annual return of 10.03%. Currently, Cigna has a market capitalization of $77.61 billion.

Amid logistical disruptions and high inflation, aggressive Federal Reserve rate increases might hamper the economic recovery. However, improving job data and ongoing diplomatic talks concerning the Russia-Ukraine war have fostered fresh hopes for a solid stock market recovery in the near term. Therefore, we think it could be wise to…

Inflation has surged to multi-year highs, so the Fed is contemplating raising interest rates aggressively this year. And an increasing interest rate environment typically translates to revenue growth for financial companies, including insurers. Thus, we think it could be wise to bet on quality insurance stocks Cigna (CI), Humana (HUM),…

Cigna (NYSE:CI) has outperformed the market over the past 20 years by 3.54% on an annualized basis.

Over the past 3 months, 9 analysts have published their opinion on Cigna (NYSE:CI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.